The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*
暂无分享,去创建一个
P. Pandharipande | E. Ely | T. Girard | A. Morandi | A. Shintani | Jennifer L. Thompson | C. Boomershine | Jessica R Adams Wilson | E. W. Ely | Jessica R. Adams Wilson | Chad S. Boomershine
[1] R. Baronica,et al. [Pathophysiology of delirium]. , 2012, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[2] B. Brew,et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat , 2011, Journal of NeuroVirology.
[3] E. Ely,et al. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients* , 2010, Critical care medicine.
[4] A. Zwinderman,et al. Cortisol, interleukins and S100B in delirium in the elderly , 2010, Brain and Cognition.
[5] R. Stevens,et al. Septic-associated encephalopathy - everything starts at a microlevel , 2010, Critical care.
[6] G. Bernard,et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness , 2010, Critical care medicine.
[7] E. Mukaetova-Ladinska,et al. The neuroinflammatory hypothesis of delirium , 2010, Acta Neuropathologica.
[8] A. Zwinderman,et al. Serum S100B in elderly patients with and without delirium , 2010, International journal of geriatric psychiatry.
[9] Stanislav V Kasl,et al. Days of delirium are associated with 1-year mortality in an older intensive care unit population. , 2009, American journal of respiratory and critical care medicine.
[10] Gilles J. Guillemin,et al. The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons , 2009, PloS one.
[11] P. Pandharipande,et al. Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients , 2009, Intensive Care Medicine.
[12] P. Scully,et al. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation , 2009, Journal of psychopharmacology.
[13] G. Guillemin,et al. Kynurenine Pathway Metabolites in Humans: Disease and Healthy States , 2009, International journal of tryptophan research : IJTR.
[14] G. Costantino. New promises for manipulation of kynurenine pathway in cancer and neurological diseases. , 2009, Expert opinion on therapeutic targets.
[15] J. Maldonado. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. , 2008, Critical care clinics.
[16] R. Dittus,et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. , 2008, The Journal of trauma.
[17] S. Marsch,et al. Cerebral perfusion in sepsis-associated delirium , 2008, Critical care.
[18] B. Brew,et al. Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity , 2008, Journal of neurochemistry.
[19] I. Puzanov,et al. Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study. , 2007, Journal of mass spectrometry : JMS.
[20] E. Ely,et al. Pathophysiology of delirium in the intensive care unit. , 2008, Critical care clinics.
[21] Russell R. Miller,et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. , 2007, JAMA.
[22] G. Oxenkrug. Genetic and Hormonal Regulation of Tryptophan–Kynurenine Metabolism , 2007, Annals of the New York Academy of Sciences.
[23] J. Toldi,et al. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders , 2007, Journal of the Neurological Sciences.
[24] F. Martin,et al. C-reactive protein levels predict the incidence of delirium and recovery from it. , 2007, Age and ageing.
[25] L. Ferrucci,et al. Elucidating the pathophysiology of delirium and the interrelationship of delirium and dementia. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[26] J. Seibyl,et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[27] D. Fuchs,et al. Monitoring tryptophan metabolism in chronic immune activation. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[28] T. Stone,et al. Tryptophan metabolism and oxidative stress in patients with chronic brain injury , 2006, European journal of neurology.
[29] G. Bernard,et al. Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit Patients , 2006, Anesthesiology.
[30] S. Gottfried,et al. Incidence, risk factors and consequences of ICU delirium , 2006, Intensive Care Medicine.
[31] V. Meininger,et al. Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis , 2006, Neurodegenerative Diseases.
[32] B. Brew,et al. Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus , 2005, Neuropathology and applied neurobiology.
[33] J. Peterson,et al. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients , 2005, Critical care.
[34] H. Takase,et al. Postoperative Interleukin-6 and Cortisol Concentrations in Elderly Patients with Postoperative Confusion , 2005, Neuroimmunomodulation.
[35] Yueh-Fu Fang,et al. The impact of delirium on the survival of mechanically ventilated patients* , 2004, Critical care medicine.
[36] R. Hopkins,et al. The Association Between Delirium and Cognitive Decline: A Review of the Empirical Literature , 2004, Neuropsychology Review.
[37] Theodore Speroff,et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. , 2004, JAMA.
[38] G. Bernard,et al. Costs associated with delirium in mechanically ventilated patients* , 2004, Critical care medicine.
[39] T. Stone,et al. Tryptophan Loading Induces Oxidative Stress , 2004, Free radical research.
[40] A. Sherman,et al. l-Kynurenine Its synthesis and possible regulatory function in brain , 1980, Neurochemical Research.
[41] M. C. Lewis,et al. Postoperative delirium: the tryptophan dyregulation model. , 2004, Medical hypotheses.
[42] Theodore Speroff,et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). , 2003, JAMA.
[43] M. Pisani,et al. Delirium in the Intensive Care Unit: Occurrence and Clinical Course in Older Patients , 2003, Journal of the American Geriatrics Society.
[44] E. Ragazzi,et al. Kynurenine pathway enzymes in different species of animals. , 2003, Advances in experimental medicine and biology.
[45] C. Sessler,et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. , 2002, American journal of respiratory and critical care medicine.
[46] R. Schwarcz,et al. Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities , 2002, Journal of Pharmacology and Experimental Therapeutics.
[47] B. Brew,et al. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease , 2002, Redox report : communications in free radical research.
[48] M. Heyes,et al. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the l‐kynurenine and quinolinic acid pools in brain , 2002, Journal of neurochemistry.
[49] H. Bojar,et al. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. , 2002, Anticancer research.
[50] G. Bernard,et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). , 2001, JAMA.
[51] G. Bernard,et al. The impact of delirium in the intensive care unit on hospital length of stay , 2001, Intensive Care Medicine.
[52] M. Seishima,et al. Lipopolysaccharide induction of indoleamine 2,3‐dioxygenase is mediated dominantly by an IFN‐γ‐independent mechanism , 2001, European journal of immunology.
[53] Theodore Speroff,et al. Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) , 2001, Critical care medicine.
[54] Y. Skrobik,et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool , 2001, Intensive Care Medicine.
[55] D. Fekkes,et al. Serotonin and amino acids: partners in delirium pathophysiology? , 2000, Seminars in clinical neuropsychiatry.
[56] B. Ishizuka,et al. Postoperative delirium and plasma melatonin. , 1999, Medical hypotheses.
[57] C. Sprung,et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.
[58] E. Sinz,et al. Quinolinic Acid is Increased in CSF and Associated with Mortality after Traumatic Brain Injury in Humans , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[59] A. van Dalen,et al. Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. , 1995, Journal of chromatography. B, Biomedical applications.
[60] Shuxian Hu,et al. Cytokine modulation of murine microglial cell superoxide production , 1995, Glia.
[61] P. Trzepacz. The neuropathogenesis of delirium. A need to focus our research. , 1994, Psychosomatics.
[62] T. Stone,et al. Neuropharmacology of quinolinic and kynurenic acids. , 1993, Pharmacological reviews.
[63] M. Demitrack,et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.
[64] Elsdon Storey,et al. Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex , 1992, Journal of the Neurological Sciences.
[65] R. Schwarcz,et al. Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism , 1991, Journal of neurochemistry.
[66] J. Sidtis,et al. Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status , 1991, Annals of neurology.
[67] A. Lackner,et al. Increased Cerebrospinal Fluid Quinolinic Acid, Kynurenic Acid, and L‐Kynurenine in Acute Septicemia , 1990, Journal of neurochemistry.
[68] A. Wyler,et al. Quinolinic Acid Concentrations in Brain and Cerebrospinal Fluid of Patients with Intractable Complex Partial Seizures , 1990, Epilepsia.
[69] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[70] S. Opella,et al. Selectively deuterated amino acid analogues. Synthesis, incorporation into proteins and NMR properties. , 1977, Biochimica et biophysica acta.